BRAF V600E Inhibition in Anaplastic Thyroid Cancer
暂无分享，去创建一个
[1] C. von Kalle,et al. BRAF inhibition in refractory hairy-cell leukemia. , 2012, The New England journal of medicine.
[2] C. Nucera,et al. Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer. , 2012, Endocrinology.
[3] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[4] T. Takano,et al. BRAFV600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas , 2007, British Journal of Cancer.
[5] M. Nikiforova,et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. , 2003, The Journal of clinical endocrinology and metabolism.